(Q38333669)

2 September 2017

title

The effects of antisense to Gialpha2 on opioid agonist potency and Gialpha2 protein and mRNA abundance in the mouse (English)

1 reference

2 September 2017

0 references

Shen J

1

1 reference

2 September 2017

Shah S

series ordinal

2

1 reference

2 September 2017

Hsu H

series ordinal

3

1 reference

2 September 2017

Yoburn BC

series ordinal

4

1 reference

2 September 2017

publication date

1 August 1998

1 reference

2 September 2017

published in

Molecular Brain Research

1 reference

2 September 2017

volume

59

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

247-255

1 reference

Antisense knockouts: molecular scalpels for the dissection of signal transduction

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Dissociation of opioid receptor upregulation and functional supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Modification of guanine nucleotide-regulatory components in brain membranes. II. Relationship of guanosine 5'-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Progress toward oligonucleotide therapeutics: pharmacodynamic properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

The effect of intrinsic efficacy on opioid tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

The effect of cumulative dosing on the analgesic potency of morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Specificity of interaction between receptor and G protein: use of antisense techniques to relate G-protein subunits to function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Modification of morphine-induced analgesia and toxicity by pertussis toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Pharmacological mechanisms of opioid analgesics.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Elevated messenger RNA levels after antisense oligodeoxynucleotide treatment in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

A Gi2alpha antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Review important concepts of receptor theory

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

A highly sensitive adenylate cyclase assay

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Antibodies directed against alpha subunits of Gi, Gx/z, GO and GS transducer proteins reduced the morphine withdrawal syndrome in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Intracerebroventricular injection of antibodies directed against Gs alpha enhances the supraspinal antinociception induced by morphine, beta-endorphin and clonidine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Pertussis toxin differentially reduces the efficacy of opioids to produce supraspinal analgesia in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Time-dependent effects of in vivo pertussis toxin on morphine analgesia and G-proteins in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Spinal and supraspinal effects of pertussis toxin on opioid analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

The effect of ethanol drinking on opioid analgesia and receptors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

The effect of in vivo ethanol consumption on cyclic AMP and delta-opioid receptors in mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Antisense oligonucleotide strategies in neuropharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Improved two-step method for the assay of adenylate and guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2898%2900133-8

7 January 2021

10.1016/S0169-328X(98)00133-8

Identifiers

DOI

1 reference

2 September 2017

1 reference